Recruiting
Phase 3

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Sponsor:

Dermavant Sciences, Inc.

Code:

NCT05172726

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tapinarof cream, 1%

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information